Ken Griffin Reviva Pharmaceuticals Holdings, Inc. Transaction History
Citadel Advisors LLC
- $559 Billion
- Q4 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 351,400 shares of RVPH stock, worth $632,520. This represents 0.0% of its overall portfolio holdings.
Number of Shares
351,400
Previous 60,000
485.67%
Holding current value
$632,520
Previous $86,000
605.81%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding RVPH
# of Institutions
51Shares Held
7.83MCall Options Held
628KPut Options Held
338K-
Israel Englander Millennium Management LLC | New York, Ny1.8MShares$3.25 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.38MShares$2.49 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY1.36MShares$2.46 Million0.03% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY1.06MShares$1.9 Million0.01% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT514KShares$925,6910.13% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $36.8M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...